Novartis and Amgen plan to file migraine jab
Companies will discuss trial data with regulators.
pain
Teva and Regeneron halt back pain study
But phase 3 development continues with revised protocol
Pfizer’s Lyrica patent appeal fails in UK
Generics firms free to exploit gap in Pfizer’s patent defences.
Takeda returns rights to two Amgen drugs
Companies revise collaboration agreement.
FDA delays decision on abuse deterrence data on Endo painkiller
Data could be used to fend off generic competition.
AZ sells anaesthetics rights to Aspen
South African firm will pay $770 million.